CORRECTION article

Front. Immunol., 31 July 2025

Sec. Inflammation

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1659224

Correction: RvE1 attenuates polymicrobial sepsis-induced cardiac dysfunction and enhances bacterial clearance

  • 1. Barts and the London School of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom

  • 2. Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom

  • 3. Department of Drug Science and Technology, University of Turin, Turin, Italy

  • 4. Department of Basic Medical Sciences, School of Medicine, Al-Balqa Applied University, As-Salt, Jordan

  • 5. Diabetes Complication Research Centre, School of Medicine, UCD Conway Institute, University College Dublin, Dublin, Ireland

  • 6. Department of Intensive Care and Intermediate Care, RWTH University Hospital Aachen, Aachen, Germany

There was a mistake in Figure 3A as published. The previous image of Figure 3A (MHCII vs. SSC-A scatter plot) was selected from a mouse in the 24-hour post-CLP group that had received RvE1 treatment, as we initially understood that RvE1-treated mice were also subjected to 24-hour CLP. However, to avoid any further confusion, we have now replaced this scatter plot with an image from a mouse subjected to CLP without RvE1 treatment. This change more accurately reflects the legend of Figure 3A: “(A) Flow cytometry gating strategy of mouse peritoneal immune cells 24 h post-CLP”. The corrected Figure 3 and its caption appear below.

Figure 3

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

polymicrobial sepsis, resolvin E1, bacterial clearance, immune response, cardiomyopathy

Citation

Chen J, Purvis GSD, Collotta D, AI Zoubi S, Sugimoto MA, Cacace A, Martin L, Colas RA, Collino M, Dalli J and Thiemermann C (2025) Correction: RvE1 attenuates polymicrobial sepsis-induced cardiac dysfunction and enhances bacterial clearance. Front. Immunol. 16:1659224. doi: 10.3389/fimmu.2025.1659224

Received

03 July 2025

Accepted

18 July 2025

Published

31 July 2025

Volume

16 - 2025

Edited and reviewed by

Niccolo Terrando, Duke University, United States

Updates

Copyright

*Correspondence: Jianmin Chen, ; Christoph Thiemermann,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics